These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 11347706)
1. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. Pluhar GE; Manley PA; Heiner JP; Vanderby R; Seeherman HJ; Markel MD J Orthop Res; 2001 Mar; 19(2):308-17. PubMed ID: 11347706 [TBL] [Abstract][Full Text] [Related]
2. Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge. Zabka AG; Pluhar GE; Edwards RB; Manley PA; Hayashi K; Heiner JP; Kalscheur VL; Seeherman HJ; Markel J Orthop Res; 2001 Mar; 19(2):318-27. PubMed ID: 11347707 [TBL] [Abstract][Full Text] [Related]
3. Improved healing efficacy in canine ulnar segmental defects with increasing recombinant human bone morphogenetic protein-2/allograft ratios. Jones CB; Sabatino CT; Badura JM; Sietsema DL; Marotta JS J Orthop Trauma; 2008 Sep; 22(8):550-9. PubMed ID: 18758287 [TBL] [Abstract][Full Text] [Related]
4. rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. Seeherman HJ; Li XJ; Bouxsein ML; Wozney JM J Bone Joint Surg Am; 2010 Feb; 92(2):411-26. PubMed ID: 20124069 [TBL] [Abstract][Full Text] [Related]
5. Ridge augmentation using recombinant bone morphogenetic protein-2 techniques: an experimental study in the canine. Thoma DS; Jones A; Yamashita M; Edmunds R; Nevins M; Cochran DL J Periodontol; 2010 Dec; 81(12):1829-38. PubMed ID: 20681814 [TBL] [Abstract][Full Text] [Related]
6. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model. Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615 [TBL] [Abstract][Full Text] [Related]
7. Canine investigation of rhBMP-2, autogenous bone graft, and rhBMP-2 with autogenous bone graft for the healing of a large segmental tibial defect. Boyce AS; Reveal G; Scheid DK; Kaehr DM; Maar D; Watts M; Stone MB J Orthop Trauma; 2009; 23(10):685-92. PubMed ID: 19858976 [TBL] [Abstract][Full Text] [Related]
8. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934 [TBL] [Abstract][Full Text] [Related]
9. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939 [TBL] [Abstract][Full Text] [Related]
10. Extracortical bone-bridging fixation with use of cortical allograft and recombinant human osteogenic protein-1. Fukuroku J; Inoue N; Rafiee B; Sim FH; Frassica FJ; Chao EY J Bone Joint Surg Am; 2007 Jul; 89(7):1486-96. PubMed ID: 17606787 [TBL] [Abstract][Full Text] [Related]
11. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft. Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422 [TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. Barboza EP; Caúla AL; Caúla Fde O; de Souza RO; Geolás Neto L; Sorensen RG; Li XJ; Wikesjö UM J Periodontol; 2004 May; 75(5):702-8. PubMed ID: 15212353 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. Jones AL; Bucholz RW; Bosse MJ; Mirza SK; Lyon TR; Webb LX; Pollak AN; Golden JD; Valentin-Opran A; J Bone Joint Surg Am; 2006 Jul; 88(7):1431-41. PubMed ID: 16818967 [TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. Welch RD; Jones AL; Bucholz RW; Reinert CM; Tjia JS; Pierce WA; Wozney JM; Li XJ J Bone Miner Res; 1998 Sep; 13(9):1483-90. PubMed ID: 9738522 [TBL] [Abstract][Full Text] [Related]
15. Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Jovanovic SA; Hunt DR; Bernard GW; Spiekermann H; Wozney JM; Wikesjö UM Clin Oral Implants Res; 2007 Apr; 18(2):224-30. PubMed ID: 17348887 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. Edwards RB; Seeherman HJ; Bogdanske JJ; Devitt J; Vanderby R; Markel MD J Bone Joint Surg Am; 2004 Jul; 86(7):1425-38. PubMed ID: 15252089 [TBL] [Abstract][Full Text] [Related]
17. Bone tissue engineering by way of allograft revitalization: mechanistic and mechanical investigations using a porcine model. Runyan CM; Ali ST; Chen W; Calder BW; Rumburg AE; Billmire DA; Taylor JA J Oral Maxillofac Surg; 2014 May; 72(5):1000.e1-11. PubMed ID: 24742484 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. Sciadini MF; Johnson KD J Orthop Res; 2000 Mar; 18(2):289-302. PubMed ID: 10815831 [TBL] [Abstract][Full Text] [Related]